AAAAAA
Results:
1-15
|
Results: 15
Authors:
NAGY Z
MOHARI K
JANOKI G
CSEH K
TAKACS I
KISS L
HORVATH C
FOLDES J
LAKATOS P
Citation: Z. Nagy et al., TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND BONE-MINERAL CONTENT IN HYPERTHYROIDISM, Journal of bone and mineral research, 12, 1997, pp. 358-358
Authors:
FOLDES J
LAKATOS P
ZSADANYI J
HORVATH C
Citation: J. Foldes et al., DECREASED SERUM IGF-I AND DEHYDROEPIANDROSTERONE-SULFATE MAY BE RISK-FACTORS FOR THE DEVELOPMENT OF REDUCED BONE MASS IN POSTMENOPAUSAL WOMEN WITH ENDOGENOUS SUBCLINICAL HYPERTHYROIDISM, European journal of endocrinology, 136(3), 1997, pp. 277-281
Authors:
LAKATOS P
FOLDES J
HORVATH C
KISS L
TATRAI A
TAKACS I
TARJAN G
STERN PH
Citation: P. Lakatos et al., SERUM INTERLEUKIN-6 AND BONE METABOLISM IN PATIENTS WITH THYROID-FUNCTION DISORDERS, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 78-81
Authors:
TAKACS IK
SZABOLCS I
GOTH M
DOHAN O
KOVACS L
SZILAGYI G
FOLDES J
SENIOR M
Citation: Ik. Takacs et al., CONSENSUS STATEMENT ON MANAGEMENT OF HYPOTHYROIDISM AND HYPERTHYROIDISM - LONG-TERM TREATMENT IS NOT SAFE IN ELDERLY PATIENTS WITH TOXIC NODULAR HYPERTHYROIDISM, BMJ. British medical journal, 313(7070), 1996, pp. 1487-1487
Authors:
LAKATOS P
KISS L
HORVATH C
TAKACS I
FOLDES J
BOSSANYI A
BUZAS E
MAJOR T
Citation: P. Lakatos et al., EFFECT OF ALPHACALCIDOL ON BONE IN PATIENTS TREATED WITH GLUCOCORTICOIDS, Journal of bone and mineral research, 11, 1996, pp. 545-545
Authors:
TAKACS I
KISS L
HORVATH C
FOLDES J
LAKATOS P
Citation: I. Takacs et al., SERUM LEVELS OF TYPE-I COLLAGEN CARBOXYTERMINAL PROPEPTIDE AND BONE METABOLISM IN HYPERTHYROIDISM, Journal of bone and mineral research, 11, 1996, pp. 565-565
Authors:
LAKATOS P
TATRAI A
FOLDES J
HORVATH C
MAKO J
STERN PH
Citation: P. Lakatos et al., ENDOTHELIN CONCENTRATIONS ARE ELEVATED IN PLASMA OF PATIENTS WITH PRIMARY AND SECONDARY HYPERPARATHYROIDISM, Calcified tissue international, 58(1), 1996, pp. 70-71
Authors:
PARFITT AM
VILLANUEVA AR
FOLDES J
RAO DS
Citation: Am. Parfitt et al., RELATIONS BETWEEN HISTOLOGIC INDEXES OF BONE-FORMATION - IMPLICATIONSFOR THE PATHOGENESIS OF SPINAL OSTEOPOROSIS, Journal of bone and mineral research, 10(3), 1995, pp. 466-473
Authors:
LAKATOS P
TARRAI A
FOLDES J
KISS L
HORVATH C
MAKO J
STERN PH
Citation: P. Lakatos et al., PLASMA ENDOTHELIN LEVELS IN PRIMARY AND SECONDARY HYPERPARATHYROIDISM, Journal of bone and mineral research, 10, 1995, pp. 402-402
Authors:
ZIMRAN A
ELSTEIN D
LEVYLAHAD E
ZEVIN S
HADASHALPERN I
BARZIV Y
FOLDES J
SCHWARTZ AJ
ABRAHAMOV A
Citation: A. Zimran et al., REPLACEMENT THERAPY WITH IMIGLUCERASE FOR TYPE-1 GAUCHERS-DISEASE, Lancet, 345(8963), 1995, pp. 1479-1480
Authors:
DOLEV E
SAMUEL R
FOLDES J
BRICKMAN M
ASSIA A
LIBERMAN UA
Citation: E. Dolev et al., SOME EPIDEMIOLOGIC ASPECTS OF PAGETS-DISEASE OF BONE IN ISRAEL, Seminars in arthritis and rheumatism, 23(4), 1994, pp. 228-228
Authors:
MENCZEL J
FOLDES J
STEINBERG R
LEICHTER I
SHALITA B
BDOLAHABRAM T
KADOSH S
MAZOR Z
LADKANI D
Citation: J. Menczel et al., ALFACALCIDOL (ALPHA-D-3) AND CALCIUM IN OSTEOPOROSIS, Clinical orthopaedics and related research, (300), 1994, pp. 241-247
Authors:
MOSCOVICI A
RUBINGER D
WEISS R
FOLDES J
POPOVTZER MM
Citation: A. Moscovici et al., STIMULATION OF OSTEOCLASTIC BONE-RESORPTION IN ACUTE-RENAL-FAILURE (ARF) - EVIDENCE FOR PARATHYROID-HORMONE (PTH)-INDEPENDENT MECHANISM, Journal of bone and mineral research, 8, 1993, pp. 190000290-190000290
Authors:
FOLDES J
TARJAN G
SZATHMARI M
VARGA F
KRASZNAI I
HORVATH C
Citation: J. Foldes et al., BONE-MINERAL DENSITY IN PATIENTS WITH ENDOGENOUS SUBCLINICAL HYPERTHYROIDISM - IS THIS THYROID STATUS A RISK FACTOR FOR OSTEOPOROSIS, Clinical endocrinology, 39(5), 1993, pp. 521-527
Authors:
FOLDES J
TARJAN G
BANOS C
NEMETH J
VARGA F
BUKI B
Citation: J. Foldes et al., BIOLOGIC BLOOD MARKERS REFLECTING THYROID-HORMONE EFFECT AT PERIPHERAL TISSUE-LEVEL IN PATIENTS RECEIVING LEVOTHYROXINE REPLACEMENT FOR HYPOTHYROIDISM, Acta medica Hungarica, 48(1-2), 1991, pp. 33-43
Risultati:
1-15
|